Jyong Biotech
MENS
NASDAQ
IPO2025
about MENS
Jyong Biotech is a Taiwan-based biotechnology company focused on developing and commercializing innovative, plant-derived drugs primarily for the treatment and prevention of urinary system diseases, including benign prostate hyperplasia and prostate cancer.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $48.62 | $50.00 | $36.80 | $3.80B | 281.75K |